Active ingredientPonesimodCat. No. P-P157-001CAS 854107-55-4Family · Pharmaceutical analytical standards
Ponesimod
A selective modulator of the sphingosine-1-phosphate receptor S1P1, which keeps lymphocytes inside the lymph nodes. Approved in 2021 in the United States and Europe for relapsing forms of multiple sclerosis. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?Its effect is quickly reversible: after stopping it, lymphocyte counts return to normal within about a week in more than 90% of patients.
Go to the active ingredient →Active ingredientPonesimodCat. No. P-P157-001CAS 854107-55-4
Isotopically labelledPonesimod-d7Cat. No. P-P157-002
Impurityent-PonesimodCat. No. P-P157-003CAS 854111-49-2
ImpurityPonesimod Impurity 1Cat. No. P-P157-004CAS 1029435-58-2No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.